NBC New York /

Health

To view this site, you need to have Flash Player 8.0 or later installed. Click here to get the latest Flash player.

Move Over, Botox

The FDA is expected to approve Reloxin - a competitor to Botox - that is cheaper, faster, and longer-lasting.

You have 2000 characters left